Thaler J - Search Results

1

Reduced incidence of infusion-related reactions in metastatic colorectal cancer during treatment with cetuximab plus irinotecan with combined corticosteroid and antihistamine premedication.

Siena S, Glynne-Jones R, Adenis A, Thaler J, Preusser P, Aguilar EA, Aapro MS, Loos AH, Esser R, Wilke H. Siena S, et al. Among authors: thaler j. Cancer. 2010 Apr 1;116(7):1827-37. doi: 10.1002/cncr.24945. Cancer. 2010. PMID: 20143444 Free article.

2

Phase I/II study of first-line irinotecan combined with 5-fluorouracil and folinic acid Mayo Clinic schedule in patients with advanced colorectal cancer.

Kuehr T, Ruff P, Rapoport BL, Falk S, Daniel F, Jacobs C, Davidson N, Thaler J, Boussard B, Carmichael J. Kuehr T, et al. Among authors: thaler j. BMC Cancer. 2004 Jul 16;4:36. doi: 10.1186/1471-2407-4-36. BMC Cancer. 2004. PMID: 15257756 Free PMC article. Clinical Trial.

3

Cetuximab plus irinotecan in heavily pretreated metastatic colorectal cancer progressing on irinotecan: MABEL Study.

Wilke H, Glynne-Jones R, Thaler J, Adenis A, Preusser P, Aguilar EA, Aapro MS, Esser R, Loos AH, Siena S. Wilke H, et al. Among authors: thaler j. J Clin Oncol. 2008 Nov 20;26(33):5335-43. doi: 10.1200/JCO.2008.16.3758. Epub 2008 Oct 14. J Clin Oncol. 2008. PMID: 18854570

4

First-line panitumumab plus irinotecan/5-fluorouracil/leucovorin treatment in patients with metastatic colorectal cancer.

Köhne CH, Hofheinz R, Mineur L, Letocha H, Greil R, Thaler J, Fernebro E, Gamelin E, Decosta L, Karthaus M. Köhne CH, et al. Among authors: thaler j. J Cancer Res Clin Oncol. 2012 Jan;138(1):65-72. doi: 10.1007/s00432-011-1061-6. Epub 2011 Sep 30. J Cancer Res Clin Oncol. 2012. PMID: 21960318 Clinical Trial.

5

Skin toxicity and quality of life in patients with metastatic colorectal cancer during first-line panitumumab plus FOLFIRI treatment in a single-arm phase II study.

Thaler J, Karthaus M, Mineur L, Greil R, Letocha H, Hofheinz R, Fernebro E, Gamelin E, Baños A, Köhne CH. Thaler J, et al. BMC Cancer. 2012 Sep 29;12:438. doi: 10.1186/1471-2407-12-438. BMC Cancer. 2012. PMID: 23020584 Free PMC article. Clinical Trial.

6

Impact of tumour RAS/BRAF status in a first-line study of panitumumab + FOLFIRI in patients with metastatic colorectal cancer.

Karthaus M, Hofheinz RD, Mineur L, Letocha H, Greil R, Thaler J, Fernebro E, Oliner KS, Boedigheimer M, Twomey B, Zhang Y, Demonty G, Köhne CH. Karthaus M, et al. Among authors: thaler j. Br J Cancer. 2016 Nov 8;115(10):1215-1222. doi: 10.1038/bjc.2016.343. Epub 2016 Oct 20. Br J Cancer. 2016. PMID: 27764839 Free PMC article.

7

Prediction of mortality in metastatic colorectal cancer in a real-life population: a multicenter explorative analysis.

Rumpold H, Niedersüß-Beke D, Heiler C, Falch D, Wundsam HV, Metz-Gercek S, Piringer G, Thaler J. Rumpold H, et al. Among authors: thaler j. BMC Cancer. 2020 Nov 25;20(1):1149. doi: 10.1186/s12885-020-07656-w. BMC Cancer. 2020. PMID: 33238958 Free PMC article.

8

Oxaliplatin, irinotecan and cetuximab in advanced gastric cancer. A multicenter phase II trial (Gastric-2) of the Arbeitsgemeinschaft Medikamentose Tumortherapie (AGMT).

Wöll E, Greil R, Eisterer W, Bechter O, Fridrik MA, Grünberger B, Zabernigg A, Mayrbäurl B, Russ G, Dlaska M, Obrist P, Thaler J. Wöll E, et al. Among authors: thaler j. Anticancer Res. 2011 Dec;31(12):4439-43. Anticancer Res. 2011. PMID: 22199312 Clinical Trial.

9

Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie).

Huemer F, Thaler J, Piringer G, Hackl H, Pleyer L, Hufnagl C, Weiss L, Greil R. Huemer F, et al. Among authors: thaler j. BMC Cancer. 2018 Jan 3;18(1):11. doi: 10.1186/s12885-017-3955-4. BMC Cancer. 2018. PMID: 29298682 Free PMC article.

10

The Austrian fulvestrant registry: results from a prospective observation of fulvestrant in postmenopausal patients with metastatic breast cancer.

Bartsch R, Mlineritsch B, Gnant M, Niernberger T, Pluschnig U, Greil R, Wenzel C, Sevelda P, Thaler J, Rudas M, Pober M, Zielinski CC, Steger GG; Austrian Fulvestrant Registry. Bartsch R, et al. Among authors: thaler j. Breast Cancer Res Treat. 2009 May;115(2):373-80. doi: 10.1007/s10549-008-0132-0. Epub 2008 Jul 26. Breast Cancer Res Treat. 2009. PMID: 18661231 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

506 results

Search Page

Filters